TruTrace Technologies, a developer of a fully-integrated blockchain platform for the legal cannabis, food, and pharmaceutical industries, today announced it has signed a letter of intent with Georgia-based PharmaCentra LLC – through its subsidiary CannabisBPO — to support a clinical trial ecosystem built on standardized protocols and testing of cannabis products for use in the medical industry. “As cannabis gains acceptance as a useful component of therapies to treat serious medical conditions, it is critical to ensure that all products used for patient care are safe and consistent,” says Robert Galarza, CEO of TruTrace. “This partnership is an important step toward making that a reality because there will be repeatable, verifiable processes for measuring the efficacy of cannabis-derived compounds that the entire biopharma industry can use to improve the quality of the therapies that are available to people who need them.”

Mmp News Author, Medical Marijuana Program Connection, 03/01/2021 09:10:00

Open article: